HEADER IMMUNE SYSTEM 18-JAN-22 7QUI TITLE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SIGLEC-8 IN COMPLEX WITH TITLE 2 SULFONAMIDE SIALOSIDE ANALOGUE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SIALIC ACID-BINDING IG-LIKE LECTIN 8; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: SIGLEC-8,SIALOADHESIN FAMILY MEMBER 2,SAF-2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SIGLEC8, SAF2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SIGLEC, SIALIC ACID, ANTIBODY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR M.P.LENZA,I.OYENARTE,U.ATXABAL,C.NYCHOLAT,A.FRANCONETTI,J.I.QUINTANA, AUTHOR 2 S.DELGADO,L.UNIONE,J.PAULSON,J.JIMENEZ-BARBERO,J.ERENO-ORBEA REVDAT 3 07-FEB-24 7QUI 1 REMARK REVDAT 2 08-FEB-23 7QUI 1 JRNL REVDAT 1 18-JAN-23 7QUI 0 JRNL AUTH M.P.LENZA,U.ATXABAL,C.NYCHOLAT,I.OYENARTE,A.FRANCONETTI, JRNL AUTH 2 J.I.QUINTANA,S.DELGADO,R.NUNEZ-FRANCO,C.T.GARNICA MARROQUIN, JRNL AUTH 3 H.COELHO,L.UNIONE,G.JIMENEZ-OSES,F.MARCELO,M.SCHUBERT, JRNL AUTH 4 J.C.PAULSON,J.JIMENEZ-BARBERO,J.ERENO-ORBEA JRNL TITL STRUCTURES OF THE INHIBITORY RECEPTOR SIGLEC-8 IN COMPLEX JRNL TITL 2 WITH A HIGH-AFFINITY SIALOSIDE ANALOGUE AND A THERAPEUTIC JRNL TITL 3 ANTIBODY. JRNL REF JACS AU V. 3 204 2023 JRNL REFN ESSN 2691-3704 JRNL PMID 36711084 JRNL DOI 10.1021/JACSAU.2C00592 REMARK 2 REMARK 2 RESOLUTION. 3.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 10954 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.266 REMARK 3 R VALUE (WORKING SET) : 0.265 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 546 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.3360 - 5.3183 1.00 2698 141 0.2867 0.3037 REMARK 3 2 5.3183 - 4.2226 1.00 2604 136 0.2243 0.2862 REMARK 3 3 4.2226 - 3.6891 1.00 2555 134 0.2572 0.2468 REMARK 3 4 3.6891 - 3.3520 1.00 2551 135 0.2970 0.3348 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 126.2 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 126.7 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -7.9747 34.5283 11.8854 REMARK 3 T TENSOR REMARK 3 T11: 0.6358 T22: 1.1246 REMARK 3 T33: 0.8652 T12: -0.0104 REMARK 3 T13: -0.0981 T23: -0.1338 REMARK 3 L TENSOR REMARK 3 L11: 3.9233 L22: 0.8681 REMARK 3 L33: 3.4065 L12: -1.6663 REMARK 3 L13: -3.5509 L23: 1.1029 REMARK 3 S TENSOR REMARK 3 S11: -0.0824 S12: 0.3168 S13: -0.1604 REMARK 3 S21: -0.0947 S22: -0.2216 S23: 0.3689 REMARK 3 S31: 0.1574 S32: -0.9261 S33: 0.2474 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7QUI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1292120192. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : L REMARK 200 WAVELENGTH OR RANGE (A) : 0.71 - 2.25 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10954 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.350 REMARK 200 RESOLUTION RANGE LOW (A) : 45.840 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.16300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.47 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 2.12300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: LAUE REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7QU6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 76.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.075 M HEPES PH 7.5, 15 % PEG 10000 REMARK 280 AND 25% GLYCEROL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 100.08733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 50.04367 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 50.04367 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 100.08733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 17 REMARK 465 GLU B 18 REMARK 465 GLY B 19 REMARK 465 ASP B 20 REMARK 465 ARG B 21 REMARK 465 SER B 157 REMARK 465 LEU B 158 REMARK 465 VAL B 159 REMARK 465 PRO B 160 REMARK 465 ARG B 161 REMARK 465 GLY B 162 REMARK 465 SER B 163 REMARK 465 HIS B 164 REMARK 465 HIS B 165 REMARK 465 HIS B 166 REMARK 465 HIS B 167 REMARK 465 HIS B 168 REMARK 465 HIS B 169 REMARK 465 MET A 17 REMARK 465 GLU A 18 REMARK 465 GLY A 19 REMARK 465 ASP A 20 REMARK 465 ARG A 21 REMARK 465 LEU A 153 REMARK 465 THR A 154 REMARK 465 HIS A 155 REMARK 465 GLY A 156 REMARK 465 SER A 157 REMARK 465 LEU A 158 REMARK 465 VAL A 159 REMARK 465 PRO A 160 REMARK 465 ARG A 161 REMARK 465 GLY A 162 REMARK 465 SER A 163 REMARK 465 HIS A 164 REMARK 465 HIS A 165 REMARK 465 HIS A 166 REMARK 465 HIS A 167 REMARK 465 HIS A 168 REMARK 465 HIS A 169 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 47 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 138 -169.28 -100.47 REMARK 500 ASN B 140 13.08 59.41 REMARK 500 GLN A 138 -158.54 -156.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7QU6 RELATED DB: PDB REMARK 900 RELATED ID: 7QUH RELATED DB: PDB DBREF 7QUI B 17 155 UNP Q9NYZ4 SIGL8_HUMAN 17 155 DBREF 7QUI A 17 155 UNP Q9NYZ4 SIGL8_HUMAN 17 155 SEQADV 7QUI SER B 42 UNP Q9NYZ4 CYS 42 CONFLICT SEQADV 7QUI GLY B 156 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI SER B 157 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI LEU B 158 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI VAL B 159 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI PRO B 160 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI ARG B 161 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI GLY B 162 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI SER B 163 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS B 164 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS B 165 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS B 166 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS B 167 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS B 168 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS B 169 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI SER A 42 UNP Q9NYZ4 CYS 42 ENGINEERED MUTATION SEQADV 7QUI GLY A 156 UNP Q9NYZ4 LINKER SEQADV 7QUI SER A 157 UNP Q9NYZ4 LINKER SEQADV 7QUI LEU A 158 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI VAL A 159 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI PRO A 160 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI ARG A 161 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI GLY A 162 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI SER A 163 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS A 164 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS A 165 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS A 166 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS A 167 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS A 168 UNP Q9NYZ4 EXPRESSION TAG SEQADV 7QUI HIS A 169 UNP Q9NYZ4 EXPRESSION TAG SEQRES 1 B 153 MET GLU GLY ASP ARG GLN TYR GLY ASP GLY TYR LEU LEU SEQRES 2 B 153 GLN VAL GLN GLU LEU VAL THR VAL GLN GLU GLY LEU SER SEQRES 3 B 153 VAL HIS VAL PRO CYS SER PHE SER TYR PRO GLN ASP GLY SEQRES 4 B 153 TRP THR ASP SER ASP PRO VAL HIS GLY TYR TRP PHE ARG SEQRES 5 B 153 ALA GLY ASP ARG PRO TYR GLN ASP ALA PRO VAL ALA THR SEQRES 6 B 153 ASN ASN PRO ASP ARG GLU VAL GLN ALA GLU THR GLN GLY SEQRES 7 B 153 ARG PHE GLN LEU LEU GLY ASP ILE TRP SER ASN ASP CYS SEQRES 8 B 153 SER LEU SER ILE ARG ASP ALA ARG LYS ARG ASP LYS GLY SEQRES 9 B 153 SER TYR PHE PHE ARG LEU GLU ARG GLY SER MET LYS TRP SEQRES 10 B 153 SER TYR LYS SER GLN LEU ASN TYR LYS THR LYS GLN LEU SEQRES 11 B 153 SER VAL PHE VAL THR ALA LEU THR HIS GLY SER LEU VAL SEQRES 12 B 153 PRO ARG GLY SER HIS HIS HIS HIS HIS HIS SEQRES 1 A 153 MET GLU GLY ASP ARG GLN TYR GLY ASP GLY TYR LEU LEU SEQRES 2 A 153 GLN VAL GLN GLU LEU VAL THR VAL GLN GLU GLY LEU SER SEQRES 3 A 153 VAL HIS VAL PRO CYS SER PHE SER TYR PRO GLN ASP GLY SEQRES 4 A 153 TRP THR ASP SER ASP PRO VAL HIS GLY TYR TRP PHE ARG SEQRES 5 A 153 ALA GLY ASP ARG PRO TYR GLN ASP ALA PRO VAL ALA THR SEQRES 6 A 153 ASN ASN PRO ASP ARG GLU VAL GLN ALA GLU THR GLN GLY SEQRES 7 A 153 ARG PHE GLN LEU LEU GLY ASP ILE TRP SER ASN ASP CYS SEQRES 8 A 153 SER LEU SER ILE ARG ASP ALA ARG LYS ARG ASP LYS GLY SEQRES 9 A 153 SER TYR PHE PHE ARG LEU GLU ARG GLY SER MET LYS TRP SEQRES 10 A 153 SER TYR LYS SER GLN LEU ASN TYR LYS THR LYS GLN LEU SEQRES 11 A 153 SER VAL PHE VAL THR ALA LEU THR HIS GLY SER LEU VAL SEQRES 12 A 153 PRO ARG GLY SER HIS HIS HIS HIS HIS HIS HET F9I B 201 63 HET F9I A 201 63 HETNAM F9I (2~{S},4~{S},5~{R},6~{R})-5-ACETAMIDO-2-[(2~{S},3~{R}, HETNAM 2 F9I 4~{S},5~{S},6~{R})-2-[(2~{R},3~{S},4~{R},5~{R},6~{R})- HETNAM 3 F9I 5-ACETAMIDO-2-(HYDROXYMETHYL)-4,6-BIS(OXIDANYL)OXAN-3- HETNAM 4 F9I YL]OXY-3,5-BIS(OXIDANYL)-6-(SULFOOXYMETHYL)OXAN-4- HETNAM 5 F9I YL]OXY-6-[(1~{R},2~{R})-3-(NAPHTHALEN-2- HETNAM 6 F9I YLSULFONYLAMINO)-1,2-BIS(OXIDANYL)PROPYL]-4-OXIDANYL- HETNAM 7 F9I OXANE-2-CARBOXYLIC ACID FORMUL 3 F9I 2(C35 H49 N3 O23 S2) HELIX 1 AA1 ARG B 115 LYS B 119 5 5 SHEET 1 AA1 2 LEU B 28 GLN B 30 0 SHEET 2 AA1 2 SER B 48 SER B 50 -1 O SER B 48 N GLN B 30 SHEET 1 AA2 5 LEU B 34 GLN B 38 0 SHEET 2 AA2 5 LEU B 146 THR B 151 1 O PHE B 149 N VAL B 35 SHEET 3 AA2 5 GLY B 120 ARG B 128 -1 N TYR B 122 O LEU B 146 SHEET 4 AA2 5 VAL B 62 ARG B 68 -1 N TYR B 65 O ARG B 125 SHEET 5 AA2 5 ALA B 80 THR B 81 -1 O ALA B 80 N TRP B 66 SHEET 1 AA3 4 LEU B 34 GLN B 38 0 SHEET 2 AA3 4 LEU B 146 THR B 151 1 O PHE B 149 N VAL B 35 SHEET 3 AA3 4 GLY B 120 ARG B 128 -1 N TYR B 122 O LEU B 146 SHEET 4 AA3 4 MET B 131 SER B 134 -1 O TRP B 133 N LEU B 126 SHEET 1 AA4 3 VAL B 43 VAL B 45 0 SHEET 2 AA4 3 LEU B 109 ILE B 111 -1 O LEU B 109 N VAL B 45 SHEET 3 AA4 3 PHE B 96 LEU B 98 -1 N GLN B 97 O SER B 110 SHEET 1 AA5 2 LEU A 28 VAL A 31 0 SHEET 2 AA5 2 CYS A 47 SER A 50 -1 O SER A 48 N GLN A 30 SHEET 1 AA6 5 LEU A 34 GLN A 38 0 SHEET 2 AA6 5 LEU A 146 THR A 151 1 O PHE A 149 N VAL A 35 SHEET 3 AA6 5 GLY A 120 ARG A 128 -1 N GLY A 120 O VAL A 148 SHEET 4 AA6 5 HIS A 63 ARG A 68 -1 N TYR A 65 O ARG A 125 SHEET 5 AA6 5 ALA A 80 THR A 81 -1 O ALA A 80 N TRP A 66 SHEET 1 AA7 4 LEU A 34 GLN A 38 0 SHEET 2 AA7 4 LEU A 146 THR A 151 1 O PHE A 149 N VAL A 35 SHEET 3 AA7 4 GLY A 120 ARG A 128 -1 N GLY A 120 O VAL A 148 SHEET 4 AA7 4 MET A 131 TYR A 135 -1 O TRP A 133 N LEU A 126 SHEET 1 AA8 3 VAL A 43 VAL A 45 0 SHEET 2 AA8 3 LEU A 109 ILE A 111 -1 O LEU A 109 N VAL A 45 SHEET 3 AA8 3 PHE A 96 LEU A 98 -1 N GLN A 97 O SER A 110 SSBOND 1 CYS B 47 CYS B 107 1555 1555 2.03 SSBOND 2 CYS A 47 CYS A 107 1555 1555 2.03 CRYST1 91.682 91.682 150.131 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010907 0.006297 0.000000 0.00000 SCALE2 0.000000 0.012595 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006661 0.00000